rb 104 has been researched along with cgs 26129 in 1 studies
Studies (rb 104) | Trials (rb 104) | Recent Studies (post-2010) (rb 104) | Studies (cgs 26129) | Trials (cgs 26129) | Recent Studies (post-2010) (cgs 26129) |
---|---|---|---|---|---|
7 | 0 | 0 | 9 | 1 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burrell, LM; Casely, D; Farina, N; Johnston, CI; Risvanis, J; Woollard, D | 1 |
1 other study(ies) available for rb 104 and cgs 26129
Article | Year |
---|---|
Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
Topics: Administration, Oral; Animals; Atrial Natriuretic Factor; Binding, Competitive; Dose-Response Relationship, Drug; Female; gamma-Aminobutyric Acid; Iodine Radioisotopes; Iodobenzenes; Kidney; Methionine; Neprilysin; Peptidyl-Dipeptidase A; Prodrugs; Rats; Rats, Sprague-Dawley; Renin; Time Factors | 1997 |